why choose us

First received: August 18, 2022

Clinical Trial: Antibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB)

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Vaccine Reaction

Study Type: Interventional


Official Title: Two-Year Prospective Study of Antibody Response and Longevity Post SARS-CoV-2 Vaccine and Their Correlation With Humoral Factors

Brief Summary: Longitudinal study on healthy subjects to investigate the longevity of the antibody response to the Pfizer-BioNTech COVID-19 vaccine. Venous blood samples will be collected on an outpatient basis from 400 adults at regular intervals (1, 2, 4, 6, 12, 18 and 24 months) after the second dose of the vaccine. In the event of the administration of a third dose, the participants already recruited will be subjected to a venous blood sample immediately before administration and subsequently at regular intervals (1, 2, 4,…

Read more